PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats

Molecular mediators of hepatic steatosis and liver injury

Jeffrey D. Browning, Jay D. Horton · Journal of Clinical Investigation · 2004 · 1.8K citations · Full text

Metabolic Disorder, Immunology, Pathology +29

Peroxisome Proliferator-Activated Receptor Alpha Target Genes

Maryam Rakhshandehroo, Bianca Knoch, Michael Müller et al. · PPAR Research · 2010 · 994 citations · Full text

Lipid Peroxidation, Target Genes, Oxidative Stress +20

Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice

Emilia Ip, Geoffrey C. Farrell, Graham Robertson et al. · Hepatology · 2003 · 473 citations · Full text

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

Paulo S. Ribeiro, Helena Cortez‐Pinto, Susana Solá et al. · The American Journal of Gastroenterology · 2004 · 379 citations

Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

Emilia Ip, Geoff Farrell, Pauline de la Μ. Hall et al. · Hepatology · 2004 · 377 citations · Full text